{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:31:52Z","timestamp":1790757112458,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00428-022-03427-z","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T02:03:10Z","timestamp":1666576990000},"page":"207-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities"],"prefix":"10.1007","volume":"482","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0397-1086","authenticated-orcid":false,"given":"Thomas A.","family":"Tousseyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"3427_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"3427_CR2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood. https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"3427_CR3","unstructured":"Jaffe ES, Stein H, Swerdlow SH (2017) Classic Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al (eds) who classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. Int Agency Res Cancer Lyon. pp 435\u2013442"},{"key":"3427_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","volume":"6","author":"JM Connors","year":"2020","unstructured":"Connors JM, Cozen W, Steidl C et al (2020) Hodgkin lymphoma. Nat Rev Dis Primers 6:61. https:\/\/doi.org\/10.1038\/s41572-020-0189-6","journal-title":"Nat Rev Dis Primers"},{"key":"3427_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.pathol.2019.09.005","volume":"52","author":"MA Piris","year":"2020","unstructured":"Piris MA, Medeiros LJ, Chang K-C (2020) Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis. Pathology 52:154\u2013165. https:\/\/doi.org\/10.1016\/j.pathol.2019.09.005","journal-title":"Pathology"},{"key":"3427_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjh.18063","volume":"197","author":"ES Jaffe","year":"2022","unstructured":"Jaffe ES (2022) Lymphoma nomenclature - what\u2019s in a name? Br J Haematol 197:539\u2013543. https:\/\/doi.org\/10.1111\/bjh.18063","journal-title":"Br J Haematol"},{"key":"3427_CR7","first-page":"1889","volume":"96","author":"I Anagnostopoulos","year":"2000","unstructured":"Anagnostopoulos I, Hansmann ML, Franssila K et al (2000) European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96:1889\u20131899","journal-title":"Blood"},{"key":"3427_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/modpathol.2009.54","volume":"22","author":"SH Nam-Cha","year":"2009","unstructured":"Nam-Cha SH, Montes-Moreno S, Salcedo MT et al (2009) Lymphocyte-rich classical Hodgkin\u2019s lymphoma: distinctive tumor and microenvironment markers. Mod Pathol 22:1006\u20131015. https:\/\/doi.org\/10.1038\/modpathol.2009.54","journal-title":"Mod Pathol"},{"key":"3427_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1182\/blood-2016-11-746701","volume":"129","author":"C Steidl","year":"2017","unstructured":"Steidl C (2017) Exposing Hodgkin-Reed-Sternberg cells. Blood 129:6\u20137. https:\/\/doi.org\/10.1182\/blood-2016-11-746701","journal-title":"Blood"},{"key":"3427_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.anndiagpath.2019.02.001","volume":"39","author":"DP O\u2019Malley","year":"2019","unstructured":"O\u2019Malley DP, Dogan A, Fedoriw Y et al (2019) American Registry of Pathology Expert Opinions: immunohistochemical evaluation of classic Hodgkin lymphoma. Ann Diagn Pathol 39:105\u2013110. https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.02.001","journal-title":"Ann Diagn Pathol"},{"key":"3427_CR11","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.humpath.2013.04.011","volume":"44","author":"H Tang","year":"2013","unstructured":"Tang H, Wei Q, Ge J et al (2013) IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma. Hum pathol 44:2167\u20132172. https:\/\/doi.org\/10.1016\/j.humpath.2013.04.011","journal-title":"Hum pathol"},{"key":"3427_CR12","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/modpathol.3800473","volume":"18","author":"A Tzankov","year":"2005","unstructured":"Tzankov A, Bourgau C, Kaiser A et al (2005) Rare expression of T-cell markers in classical Hodgkin\u2019s lymphoma. Mod Pathol 18:1542\u20131549. https:\/\/doi.org\/10.1038\/modpathol.3800473","journal-title":"Mod Pathol"},{"key":"3427_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/PAI.0000000000000581","volume":"27","author":"B Kezlarian","year":"2019","unstructured":"Kezlarian B, Alhyari M, Venkataraman G et al (2019) GATA3 Immunohistochemical staining in Hodgkin lymphoma: diagnostic utility in differentiating Classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and other mimicking entities. Appl Immunohistochem Mol Morphol 27:180\u2013184. https:\/\/doi.org\/10.1097\/PAI.0000000000000581","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"3427_CR14","doi-asserted-by":"publisher","unstructured":"Bosch-Schips J, Granai M, Quintanilla-Martinez L, Fend F (2022) The grey zones of classic Hodgkin lymphoma. Cancers (Basel)\u00a0 14(3):742.\u00a0https:\/\/doi.org\/10.3390\/cancers14030742","DOI":"10.3390\/cancers14030742"},{"key":"3427_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","volume":"35","author":"MA Weniger","year":"2021","unstructured":"Weniger MA, K\u00fcppers R (2021) Molecular biology of Hodgkin lymphoma. Leukemia 35:968\u2013981. https:\/\/doi.org\/10.1038\/s41375-021-01204-6","journal-title":"Leukemia"},{"key":"3427_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5644\/ama2006-124.329","volume":"50","author":"AM Perry","year":"2021","unstructured":"Perry AM, Smith LB, Bagg A (2021) Classic Hodgkin lymphoma - old disease, new directions: an update on pathology, molecular features and biological prognostic markers. Acta Med Acad 50:110\u2013125. https:\/\/doi.org\/10.5644\/ama2006-124.329","journal-title":"Acta Med Acad"},{"key":"3427_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","volume":"132","author":"FZ Cader","year":"2018","unstructured":"Cader FZ, Schackmann RCJ, Hu X et al (2018) Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment. Blood 132:825\u2013836. https:\/\/doi.org\/10.1182\/blood-2018-04-843714","journal-title":"Blood"},{"key":"3427_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","volume":"10","author":"T Aoki","year":"2020","unstructured":"Aoki T, Chong LC, Takata K et al (2020) Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma. Canc Discov 10:406\u2013421. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0680","journal-title":"Canc Discov"},{"key":"3427_CR19","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1182\/blood-2013-06-508044","volume":"122","author":"P Greaves","year":"2013","unstructured":"Greaves P, Clear A, Owen A et al (2013) Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood 122:2856\u20132863. https:\/\/doi.org\/10.1182\/blood-2013-06-508044","journal-title":"Blood"},{"key":"3427_CR20","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1182\/bloodadvances.2017007260","volume":"1","author":"AS Duffield","year":"2017","unstructured":"Duffield AS, Ascierto ML, Anders RA et al (2017) Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy. Blood Adv 1:1324\u20131334. https:\/\/doi.org\/10.1182\/bloodadvances.2017007260","journal-title":"Blood Adv"},{"key":"3427_CR21","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","volume":"34","author":"MGM Roemer","year":"2016","unstructured":"Roemer MGM, Advani RH, Ligon AH et al (2016) PD-L1 and PD-L2 genetic alterations define classical Hodgkin Lymphoma and predict outcome. J Clin Oncol 34:2690\u20132697. https:\/\/doi.org\/10.1200\/JCO.2016.66.4482","journal-title":"J Clin Oncol"},{"key":"3427_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21037\/aol-21-8","volume":"5","author":"K Vrzalikova","year":"2021","unstructured":"Vrzalikova K, Pugh M, Mundo L, Murray P (2021) The contribution of EBV to the pathogenesis of classical Hodgkin lymphoma. Ann Lymphoma 5:30\u201330. https:\/\/doi.org\/10.21037\/aol-21-8","journal-title":"Ann Lymphoma"},{"key":"3427_CR23","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","volume":"3","author":"K Wienand","year":"2019","unstructured":"Wienand K, Chapuy B, Stewart C et al (2019) Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv 3:4065\u20134080. https:\/\/doi.org\/10.1182\/bloodadvances.2019001012","journal-title":"Blood Adv"},{"key":"3427_CR24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cancergen.2016.08.006","volume":"209","author":"ND Montgomery","year":"2016","unstructured":"Montgomery ND, Coward WB, Johnson S et al (2016) Karyotypic abnormalities associated with Epstein-Barr virus status in classical Hodgkin lymphoma. Cancer Genet 209:408\u2013416. https:\/\/doi.org\/10.1016\/j.cancergen.2016.08.006","journal-title":"Cancer Genet"},{"key":"3427_CR25","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","volume":"131","author":"E Tiacci","year":"2018","unstructured":"Tiacci E, Ladewig E, Schiavoni G et al (2018) Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood 131:2454\u20132465. https:\/\/doi.org\/10.1182\/blood-2017-11-814913","journal-title":"Blood"},{"key":"3427_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.20090528","volume":"206","author":"R Schmitz","year":"2009","unstructured":"Schmitz R, Hansmann M-L, Bohle V et al (2009) TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 206:981\u2013989. https:\/\/doi.org\/10.1084\/jem.20090528","journal-title":"J Exp Med"},{"key":"3427_CR27","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","volume":"18","author":"MR Green","year":"2012","unstructured":"Green MR, Rodig S, Juszczynski P et al (2012) Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res 18:1611\u20131618. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1942","journal-title":"Clin Cancer Res"},{"key":"3427_CR28","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1182\/blood-2008-07-168096","volume":"113","author":"B Chetaille","year":"2009","unstructured":"Chetaille B, Bertucci F, Finetti P et al (2009) Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood 113:2765\u20133775. https:\/\/doi.org\/10.1182\/blood-2008-07-168096","journal-title":"Blood"},{"key":"3427_CR29","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1038\/bcj.2017.102","volume":"8","author":"R Wu","year":"2018","unstructured":"Wu R, Sattarzadeh A, Rutgers B et al (2018) The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor. Blood Cancer J 8:e622. https:\/\/doi.org\/10.1038\/bcj.2017.102","journal-title":"Blood Cancer J"},{"key":"3427_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","volume":"27","author":"T Oyama","year":"2003","unstructured":"Oyama T, Ichimura K, Suzuki R et al (2003) Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 27:16\u201326. https:\/\/doi.org\/10.1097\/00000478-200301000-00003","journal-title":"Am J Surg Pathol"},{"key":"3427_CR31","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/1097-0142(19891015)64:8<1686::aid-cncr2820640822>3.0.co;2-i","volume":"64","author":"KA MacLennan","year":"1989","unstructured":"MacLennan KA, Bennett MH, Tu A et al (1989) Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin\u2019s disease. A study of 1659 patients. Cancer 64:1686\u20131693. https:\/\/doi.org\/10.1002\/1097-0142(19891015)64:8%3c1686::aid-cncr2820640822%3e3.0.co;2-i","journal-title":"Cancer"},{"key":"3427_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2040620716676256","volume":"8","author":"T Sethi","year":"2017","unstructured":"Sethi T, Nguyen V, Li S et al (2017) Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma. Ther Adv Hematol 8:13\u201320. https:\/\/doi.org\/10.1177\/2040620716676256","journal-title":"Ther Adv Hematol"},{"key":"3427_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/cancers10040107","volume":"10","author":"IA Montes-Mojarro","year":"2018","unstructured":"Montes-Mojarro IA, Steinhilber J, Bonzheim I et al (2018) The pathological spectrum of systemic anaplastic large cell lymphoma (ALCL). Cancers (Basel) 10:107. https:\/\/doi.org\/10.3390\/cancers10040107","journal-title":"Cancers (Basel)"},{"key":"3427_CR34","doi-asserted-by":"publisher","unstructured":"Parente P, Zanelli M, Sanguedolce F et al (2020) Hodgkin Reed-Sternberg-like cells in non-Hodgkin lymphoma. Diagnostics (Basel) 10(12):1019. https:\/\/doi.org\/10.3390\/diagnostics10121019","DOI":"10.3390\/diagnostics10121019"},{"key":"3427_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/pathogens7010028","volume":"7","author":"SD Dojcinov","year":"2018","unstructured":"Dojcinov SD, Fend F, Quintanilla-Martinez L (2018) EBV-Positive lymphoproliferations of B- T- and NK-cell derivation in non-immunocompromised hosts. Pathogens 7:28. https:\/\/doi.org\/10.3390\/pathogens7010028","journal-title":"Pathogens"},{"key":"3427_CR36","doi-asserted-by":"publisher","unstructured":"Quintanilla-Martinez L, Swerdlow S, Tousseyn T et al (2022) New concepts in EBV-associated B, T and NK-cell lymphoproliferative disorders. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-022-03414-4","DOI":"10.1007\/s00428-022-03414-4"},{"key":"3427_CR37","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","volume":"37","author":"A Nicolae","year":"2013","unstructured":"Nicolae A, Pittaluga S, Venkataraman G et al (2013) Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage. Am J Surg Pathol 37:816\u2013826. https:\/\/doi.org\/10.1097\/PAS.0b013e3182785610","journal-title":"Am J Surg Pathol"},{"key":"3427_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/ajcp\/aqaa249","volume":"156","author":"I Abukhiran","year":"2021","unstructured":"Abukhiran I, Syrbu SI, Holman CJ (2021) Markers of follicular helper T cells are occasionally expressed in T-cell or histiocyte-rich large B-cell lymphoma, classic Hodgkin lymphoma, and atypical paracortical hyperplasiaA diagnostic pitfall for T-cell lymphomas of T follicular helper origin. Am J Clin Pathol 156:409\u2013426. https:\/\/doi.org\/10.1093\/ajcp\/aqaa249","journal-title":"Am J Clin Pathol"},{"key":"3427_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1182\/bloodadvances.2020003201","volume":"5","author":"K Karube","year":"2021","unstructured":"Karube K, Takatori M, Sakihama S et al (2021) Clinicopathological features of adult T-cell leukemia\/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells. Blood Adv 5:198\u2013206. https:\/\/doi.org\/10.1182\/bloodadvances.2020003201","journal-title":"Blood Adv"},{"key":"3427_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.humpath.2016.04.019","volume":"55","author":"W Xiao","year":"2016","unstructured":"Xiao W, Chen WW, Sorbara L et al (2016) Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Hum Pathol 55:108\u2013116. https:\/\/doi.org\/10.1016\/j.humpath.2016.04.019","journal-title":"Hum Pathol"},{"key":"3427_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41408-022-00616-6","volume":"12","author":"RL King","year":"2022","unstructured":"King RL, Gupta A, Kurtin PJ et al (2022) Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs classic Hodgkin lymphoma transformation of CLL: does this distinction matter? Blood Cancer J 12:18. https:\/\/doi.org\/10.1038\/s41408-022-00616-6","journal-title":"Blood Cancer J"},{"key":"3427_CR42","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/S2352-3026(14)00039-8","volume":"2","author":"P Vandenberghe","year":"2015","unstructured":"Vandenberghe P, Wlodarska I, Tousseyn T et al (2015) Non-invasive detection of genomic imbalances in Hodgkin\/Reed-Sternberg cells in early and advanced stage Hodgkin\u2019s lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study. Lancet Haematol 2:e55-65. https:\/\/doi.org\/10.1016\/S2352-3026(14)00039-8","journal-title":"Lancet Haematol"},{"key":"3427_CR43","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1182\/bloodadvances.2020003039","volume":"5","author":"L Buedts","year":"2021","unstructured":"Buedts L, Wlodarska I, Finalet-Ferreiro J et al (2021) The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA. Blood Adv 5:1991\u20132002. https:\/\/doi.org\/10.1182\/bloodadvances.2020003039","journal-title":"Blood Adv"},{"key":"3427_CR44","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","volume":"24","author":"FC Eberle","year":"2011","unstructured":"Eberle FC, Salaverria I, Steidl C et al (2011) Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol 24:1586\u20131597. https:\/\/doi.org\/10.1038\/modpathol.2011.116","journal-title":"Mod Pathol"},{"key":"3427_CR45","unstructured":"Jaffe ES, Stein H, Swerdlow SH et al (2017) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classic Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. Int Agency Res Cancer Lyon. pp 342\u2013344"},{"key":"3427_CR46","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1182\/blood.2020007507","volume":"137","author":"C Sarkozy","year":"2021","unstructured":"Sarkozy C, Hung SS, Chavez EA et al (2021) Mutational landscape of gray zone lymphoma. Blood 137:1765\u20131776. https:\/\/doi.org\/10.1182\/blood.2020007507","journal-title":"Blood"},{"key":"3427_CR47","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1182\/bloodadvances.2020001923","volume":"4","author":"C Sarkozy","year":"2020","unstructured":"Sarkozy C, Chong L, Takata K et al (2020) Gene expression profiling of gray zone lymphoma. Blood Adv 4:2523\u20132535. https:\/\/doi.org\/10.1182\/bloodadvances.2020001923","journal-title":"Blood Adv"},{"key":"3427_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3324\/haematol.2010.030809","volume":"96","author":"I Oschlies","year":"2011","unstructured":"Oschlies I, Burkhardt B, Salaverria I et al (2011) Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children. Haematologica 96:262\u2013268. https:\/\/doi.org\/10.3324\/haematol.2010.030809","journal-title":"Haematologica"},{"key":"3427_CR49","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","volume":"1","author":"M Pilichowska","year":"2017","unstructured":"Pilichowska M, Pittaluga S, Ferry JA et al (2017) Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv 1:2600\u20132609. https:\/\/doi.org\/10.1182\/bloodadvances.2017009472","journal-title":"Blood Adv"},{"key":"3427_CR50","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1182\/blood-2014-03-564906","volume":"124","author":"WH Wilson","year":"2014","unstructured":"Wilson WH, Pittaluga S, Nicolae A et al (2014) A prospective study of mediastinal gray-zone lymphoma. Blood 124:1563\u20131569. https:\/\/doi.org\/10.1182\/blood-2014-03-564906","journal-title":"Blood"},{"key":"3427_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/PAS.0000000000001198","volume":"43","author":"C Sarkozy","year":"2019","unstructured":"Sarkozy C, Copie-Bergman C, Damotte D et al (2019) Gray-zone lymphoma between cHL and large B-cell lymphoma. Am J Surg Pathol 43:341\u2013351. https:\/\/doi.org\/10.1097\/PAS.0000000000001198","journal-title":"Am J Surg Pathol"},{"key":"3427_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1158\/2643-3230.BCD-20-0009","volume":"1","author":"S Pittaluga","year":"2020","unstructured":"Pittaluga S, Nicolae A, Wright GW et al (2020) Gene expression profiling of mediastinal gray zone lymphoma and its relationship to primary mediastinal B-cell lymphoma and classical hodgkin lymphoma. Blood Cancer Discov 1:155\u2013161. https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0009","journal-title":"Blood Cancer Discov"},{"key":"3427_CR53","doi-asserted-by":"publisher","first-page":"106479","DOI":"10.1016\/j.leukres.2020.106479","volume":"100","author":"TP Vassilakopoulos","year":"2021","unstructured":"Vassilakopoulos TP, Piperidou A, Hadjiharissi E et al (2021) Development of classic Hodgkin lymphoma after successful treatment of primary mediastinal large b-cell lymphoma: results from a well-defined database. Leuk Res 100:106479. https:\/\/doi.org\/10.1016\/j.leukres.2020.106479","journal-title":"Leuk Res"},{"key":"3427_CR54","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","volume":"29","author":"A Traverse-Glehen","year":"2005","unstructured":"Traverse-Glehen A, Pittaluga S, Gaulard P et al (2005) Mediastinal gray zone lymphoma. Am J Surg Pathol 29:1411\u20131421. https:\/\/doi.org\/10.1097\/01.pas.0000180856.74572.73","journal-title":"Am J Surg Pathol"},{"key":"3427_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12308-009-0053-9","volume":"2","author":"L Quintanilla-Martinez","year":"2009","unstructured":"Quintanilla-Martinez L, de Jong D, de Mascarel A et al (2009) Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux. France J Hematopath 2:211\u2013236. https:\/\/doi.org\/10.1007\/s12308-009-0053-9","journal-title":"France J Hematopath"},{"key":"3427_CR56","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","volume":"126","author":"A Nicolae","year":"2015","unstructured":"Nicolae A, Pittaluga S, Abdullah S et al (2015) EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood 126:863\u2013872. https:\/\/doi.org\/10.1182\/blood-2015-02-630632","journal-title":"Blood"},{"key":"3427_CR57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1084\/jem.20031074","volume":"198","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Leroy K et al (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198:851\u2013862. https:\/\/doi.org\/10.1084\/jem.20031074","journal-title":"J Exp Med"},{"key":"3427_CR58","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","volume":"102","author":"KJ Savage","year":"2003","unstructured":"Savage KJ, Monti S, Kutok JL et al (2003) The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102:3871\u20133879. https:\/\/doi.org\/10.1182\/blood-2003-06-1841","journal-title":"Blood"},{"key":"3427_CR59","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1182\/blood.2019002067","volume":"134","author":"B Chapuy","year":"2019","unstructured":"Chapuy B, Stewart C, Dunford AJ et al (2019) Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade. Blood 134:2369\u20132382. https:\/\/doi.org\/10.1182\/blood.2019002067","journal-title":"Blood"},{"key":"3427_CR60","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1182\/blood.2019001126","volume":"134","author":"A Mottok","year":"2019","unstructured":"Mottok A, Hung SS, Chavez EA et al (2019) Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. Blood 134:802\u2013813. https:\/\/doi.org\/10.1182\/blood.2019001126","journal-title":"Blood"},{"key":"3427_CR61","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3324\/haematol.2010.033167","volume":"96","author":"FC Eberle","year":"2011","unstructured":"Eberle FC, Rodriguez-Canales J, Wei L et al (2011) Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin\u2019s lymphoma and primary mediastinal large B-cell lymphoma. Haematologica 96:558\u2013566. https:\/\/doi.org\/10.3324\/haematol.2010.033167","journal-title":"Haematologica"},{"key":"3427_CR62","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/00000478-199405000-00014","volume":"18","author":"DY Mason","year":"1994","unstructured":"Mason DY, Banks PM, Chan J et al (1994) Nodular lymphocyte predominance Hodgkin\u2019s disease. A distinct clinicopathological entity. Am J Surg Pathol 18:526\u2013530. https:\/\/doi.org\/10.1097\/00000478-199405000-00014","journal-title":"Am J Surg Pathol"},{"key":"3427_CR63","unstructured":"Stein H, Swerdlow SH, Gascoyne RD et al (2017) Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al (eds) WHO classification of tumors of haematopoietic and lymphoid tissues, revised 4th edition. Int Agency Res Cancer Lyon. pp 431\u2013434"},{"key":"3427_CR64","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pathol.2019.10.003","volume":"52","author":"S Hartmann","year":"2020","unstructured":"Hartmann S, Eichenauer DA (2020) Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell\/histiocyte rich large B-cell lymphoma. Pathology 52:142\u2013153. https:\/\/doi.org\/10.1016\/j.pathol.2019.10.003","journal-title":"Pathology"},{"key":"3427_CR65","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/01.pas.0000194741.87798.45","volume":"30","author":"S Prakash","year":"2006","unstructured":"Prakash S, Fountaine T, Raffeld M et al (2006) IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 30:585\u2013592. https:\/\/doi.org\/10.1097\/01.pas.0000194741.87798.45","journal-title":"Am J Surg Pathol"},{"key":"3427_CR66","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/s41467-020-16375-6","volume":"11","author":"L Thurner","year":"2020","unstructured":"Thurner L, Hartmann S, Fadle N et al (2020) Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma. Nature Commun 11:2465. https:\/\/doi.org\/10.1038\/s41467-020-16375-6","journal-title":"Nature Commun"},{"key":"3427_CR67","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3324\/haematol.2018.203224","volume":"104","author":"B Schuhmacher","year":"2019","unstructured":"Schuhmacher B, Bein J, Rausch T et al (2019) JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma. Haematologica 104:330\u2013337. https:\/\/doi.org\/10.3324\/haematol.2018.203224","journal-title":"Haematologica"},{"key":"3427_CR68","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/leu.2015.328","volume":"30","author":"S Hartmann","year":"2016","unstructured":"Hartmann S, Schuhmacher B, Rausch T et al (2016) Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia 30:844\u2013853. https:\/\/doi.org\/10.1038\/leu.2015.328","journal-title":"Leukemia"},{"key":"3427_CR69","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","volume":"27","author":"Z Fan","year":"2003","unstructured":"Fan Z, Natkunam Y, Bair E et al (2003) Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346\u20131356. https:\/\/doi.org\/10.1097\/00000478-200310000-00007","journal-title":"Am J Surg Pathol"},{"key":"3427_CR70","doi-asserted-by":"publisher","unstructured":"Hartmann S, Eichenauer DA, Pl\u00fctschow A et al (2013) The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 122:4246\u201352; quiz 4292. https:\/\/doi.org\/10.1182\/blood-2013-07-515825","DOI":"10.1182\/blood-2013-07-515825"},{"key":"3427_CR71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.humpath.2017.08.015","volume":"68","author":"EM Moore","year":"2017","unstructured":"Moore EM, Swerdlow SH, Gibson SE (2017) J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Hum Pathol 68:47\u201353. https:\/\/doi.org\/10.1016\/j.humpath.2017.08.015","journal-title":"Hum Pathol"},{"key":"3427_CR72","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","volume":"38","author":"AR Huppmann","year":"2014","unstructured":"Huppmann AR, Nicolae A, Slack GW et al (2014) EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults. Am J Surg Pathol 38:316\u2013324. https:\/\/doi.org\/10.1097\/PAS.0000000000000107","journal-title":"Am J Surg Pathol"},{"key":"3427_CR73","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.anndiagpath.2014.03.007","volume":"18","author":"S Wang","year":"2014","unstructured":"Wang S, Medeiros LJ, Xu-Monette ZY et al (2014) Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. Ann Diagn Pathol 18:203\u2013209. https:\/\/doi.org\/10.1016\/j.anndiagpath.2014.03.007","journal-title":"Ann Diagn Pathol"},{"key":"3427_CR74","unstructured":"Ott G, Delabie J, Gascoyne RD, et al (2017) T-cell\/histiocyte-rich large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. Int Agency Res Cancer Lyon. pp 298\u2013299"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03427-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03427-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03427-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T19:20:12Z","timestamp":1674847212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03427-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3427"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03427-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"assertion":[{"value":"15 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have followed the principles of ethical and professional conduct.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}